Novel Series of Achiral, Low Molecular Weight, and Potent HIV-1 Protease Inhibitors
J. V. N. Vara Prasad(Pfizer (United States)), Bradley D. Tait(Pfizer (United States)), James B. Dunbar(Pfizer (United States)), Donna Ferguson(Pfizer (United States)), Donald Hupe(Pfizer (United States)), Kimberly S. Para(Pfizer (United States)), Elizabeth A. Lunney(Pfizer (United States)), Daniel F. Ortwine, Peter J. Tummino(Intarcia Therapeutics (United States))
Cited by 132
Related Papers
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k
Residence Time of Receptor−Ligand Complexes and Its Effect on Biological Function
|Biochemistry|2008|550